Rhodin, Kristen E.
O’Connor, Margaret H.
Beasley, Georgia M.
Article History
Received: 7 January 2025
Accepted: 13 January 2025
First Online: 18 March 2025
Disclosure
: Georgia Beasley has received clinical trial funding, paid to Duke University, from Delcath, Istari, Replimune, Oncosec, and Checkmate; and was a one-time advisory board member for BMS. Kristen E. Rhodin and Margaret H. O’Connor have no conflicts of interest to declare that may be relevant to the contents of this article.